Skip to main content
. 2022 Nov 16;20:483. doi: 10.1186/s12951-022-01691-4

Table 2.

Summary of biomolecule-mimetic nanomaterials for PTT and PDT applications

Biomolecule Nanomaterials method Advantage Type of cancer cell
Peptide AuNPs PTT Enhances the PTT efficiency of gold nanoparticles for furin-related cancer MDA-MB-468 cell [106]
pH-sensitively zwitterionic polypeptide conjugated GNRs PTT Excellent biocompatibility against normal and cell pH-sensitively released the drugs under tumoral acid condition HeLa cells [107]
cRGD@TAT-DINPs CT/PTT/PDT Excellent biological stability, combining multiple treatment methods MDA-MB-231 and A549 cell [131]
CD133-Pyro PDT More effective targeted and intraocyric accumulation effects Colorectal cancer cells [132]
IR780-M-APP NPs PDT/immunotherapy Targeted tumors and eradicated the metastatic and invasive tumors effectively B16F10 cell [134]
Protein E72-Chitosan-Ag3AuS2 hybrid hydrogel PTT High biocompatibility and photothermal conversion efficiency Tongue cancer cell [109]
BSA-Ag2S NPs PTT Biocompatibility HeLa cells [110]
Tf-RuNPs PTT Biocompatibility and stability HEK-293 cell [111]
Ce6/Cyt c @ZIF-8/HA NPs PDT Overcomes the PDT induced hypoxia to further increase PDT efficiency HeLa cell and SMMC7721 cell [135]
Bioinspired oxygen nanocarrier (C@HPOC) PDT Destroyed the primary tumors and effectively inhibited distant tumors and lung metastasis 4T1 tumor cells [136]
FA/PtBSA@MB-MSNS nanopolymers PDT Overcomes the PDT induced hypoxia to further increase PDT efficiency 4T1 tumor cells [137]
PDA PhMOSN@DOX-HA PTT/CL Biocompatible and biodegradable 4T1 tumor cell [114]
MoSe2@PDA nanocomposites PTT/CL High loading efficiency and pH-responsive Dox release effect U14 cell [115]
PDA@DOX NPs PTT/CL Targeted and high drug load 4 T1 tumor cell [116]
PDA-Dox-Pc-QRH NPs PDT/CT Chemical photodynamic combined targeted therapy A431 cell [138]
MnO2-PDA nanoshell PDT/CT Has the effect of alleviating tumor hypoxia and enhancing the PDT effect B16F10 cell [139]
RNA CuS-RNP/DOX@PEI PTT/GT/ CT Provides a potential strategy to reduce tumor thermal tolerance for enhanced mild-PTT effects A375 cell [119]
PPTC/siRNA PDT ROS-responsive siRNA release mode, PDT combined with RNAi to improve the therapeutic efficiency HepG2 cells [144]
DNA DNA-UCNP-Au hydrogels PTT Low cytotoxicity and injectable properties allow local therapy to precisely target the tumor site T24 bladder cancer cell [121]
UCNP-ApDz-TMPyP4 Nanoplatform PTT Combining PDT with gene therapy shows excellent antitumor effect Catalysis [141]
DNA Nanosponge PDT/GT Effective against hypoxia-related photodynamic resistance during PDT in vivo with good biocompatibility HeLa cells [142]
Enzyme GOIGLs (GOx) PTT Achieves milder PTT with good biocompatibility A549 cell [124]
PMF−GOx PTT/CDT Fenton reaction and moderatehyperthermia cancer treatment together MCF-7 tumor cell [125]
NC@GOx NPs PTT/CDT Combination therapy of starvation therapy, PTT and CDT for tumors 4T1 tumor cell [126]
MYR@HGNs (MYR) PTT Protect and activate the encapsulated enzymes for localized chemo-photothermal therapy 4T1 tumor cell [127]
HA-CAT@aCe6 (CAT)) PDT Overcome tumor cell hypoxia during PDT and improve the therapeutic effect of PDT MDA-MB-231 cell [146]
GOx-MSN@MnPc-LP PDT Good enzyme activity, and good therapeutic effect and safety through the synergistic treatment 4T1 tumor cell [147]
nanogel PDT Provide a new method for constructing combinatorial therapeutics with good tumor targeting ability and efficient anti-cancer effect 4T1 tumor cell [148]